Faculty profile

Paul Keown

ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Paul Keown

Researcher

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Kidney Transplantation

Latest papers

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry.
Dermatology and therapy · 2026
Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL.
Cytotherapy · 2026
HLA Experts' Perspectives on Precision Medicine and Molecular Matching in Kidney Transplantation: A Qualitative Study.
Canadian journal of kidney health and disease · 2026

All 33 publications

Latest funding

Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection
CIHR · 2021 · Co-investigator
$750,000
Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss
CIHR · 2017 · Nominated PI
$2,598,775
The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes
CIHR · 2012 · Co-investigator
$25,000

All 6 grants and awards

33 publications.

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry.

Beecker J, Albrecht L, Dei-Cas I, Gooderham M, Lynde C, Papp KA, Keown P, Vieira A, Farag MS, Maguin M, Zappitelli T, Helliwell PS

Dermatology and therapy2026

DOI: 10.1007/s13555-026-01826-7 PMID: 42479398

Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL.

Lauener MP, Normand MH, Ngo T, Abdossamadi S, Ostroumov E, Levings MK, Sherwood K, Fenninger F, Keown P, Dieudé M, Schultz KR

Cytotherapy2026

DOI: 10.1016/j.jcyt.2026.102062 PMID: 41762961

HLA Experts' Perspectives on Precision Medicine and Molecular Matching in Kidney Transplantation: A Qualitative Study.

An L, Affdal A, Ballesteros F, Malo MF, Cochran-Mavrikakis SL, Sancho C, Tousignant N, Bryan S, Keown P, Sapir-Pichhadze R, Fortin MC

Canadian journal of kidney health and disease2026

DOI: 10.1177/20543581251412195 PMID: 41657912

An integrative algorithm combining HLA epitope registry, PIRCHE-T2, and PIRCHE-B outcomes to improve immunological risk stratification in kidney transplantation.

Zhao H, Kakodkar P, Wang E, Zhang D, Niemann M, Webster D, Pearce T, Shoker A, Keown P, Sherwood K, Wu F, Lewis C, Mostafa A

Frontiers in immunology2025

DOI: 10.3389/fimmu.2025.1718506 PMID: 41624855

Canadian Kidney Transplant Recipients', Transplant Candidates', and Caregivers' Perspectives on Precision Medicine and Molecular Matching in Kidney Allocation: A Qualitative Analysis.

Ballesteros F, Affdal A, Issa M, Malo MF, Cochran-Mavrikakis SL, Sancho C, Bryan S, Keown P, Sapir-Pichhadze R, Fortin MC

Canadian journal of kidney health and disease2025

DOI: 10.1177/20543581251342440 PMID: 40417412

The John Charnley Award: The Impact of Human Leukocyte Antigen Genotype on Bacterial Infection Rates and Successful Eradication in Total Hip Arthroplasty.

Neufeld ME, Sheridan GA, MacDonell T, Howard LC, Masri BA, Keown P, Sherwood K, Garbuz DS

The Journal of arthroplasty2024

DOI: 10.1016/j.arth.2024.05.076 PMID: 38830432

Are patients with primary glomerular disease at increased risk of malignancy?

Han J, Zhao Y, Canney M, Atiquzzaman M, Keown P, Levin A, Barbour S

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2024

DOI: 10.1093/ndt/gfad261 PMID: 38070875

Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure.

Tran J, Alrajhi I, Chang D, Sherwood KR, Keown P, Gill J, Kadatz M, Gill J, Lan JH

Frontiers in genetics2024

DOI: 10.3389/fgene.2024.1383220 PMID: 38638120

Canadian Kidney Transplant Professionals' Perspectives on Precision Medicine and Molecular Matching in Kidney Allocation.

Affdal A, Ballesteros F, Malo MF, Sancho C, Cochran-Mavrikakis SL, Bryan S, Keown P, Sapir-Pichhadze R, Fortin MC

Transplantation direct2024

DOI: 10.1097/txd.0000000000001565 PMID: 38111837

NephroCAGE-German-Canadian Consortium on AI for Improved Kidney Transplantation Outcome: Protocol for an Algorithm Development and Validation Study.

Schapranow MP, Bayat M, Rasheed A, Naik M, Graf V, Schmidt D, Budde K, Cardinal H, Sapir-Pichhadze R, Fenninger F, Sherwood K, Keown P, Günther OP, Pandl KD, Leiser F, Thiebes S, Sunyaev A, Niemann M, Schimanski A, Klein T

JMIR research protocols2023

DOI: 10.2196/48892 PMID: 38133915

Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection

Co-investigatorCIHR2021Team Grant: Preparation to Trial: Inflammation for Chronic Conditions

Principal investigators: Schultz, Kirk R

Keywords: Antibody-Mediated Rejection; Biomarkers; Cell Therapeutics; Chronic Graft-Versus-Host Disease; Cytokines; Hematopoietic Stem Cell Transplantation; Immune Modulators; Solid Organ Transplantation

$750,000

Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss

Nominated PICIHR2017Genomics and Personalized Health -Large-Scale Applied Genomics Res Projects

Principal investigators: Keown, Paul A

Keywords: Kidney Transplantation

$2,598,775

The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes

Co-investigatorCIHR2012Transplantation Research - LOI

Principal investigators: West, Lori J; Caulfield, Timothy A; Hébert, Marie-Josée; Humar, Atul; Keshavjee, Shaf; Knoll, Gregory; Levings, Megan K; Mital, Seema; Roy, Denis-Claude; Schultz, Kirk R

Keywords: Bone Marrow; Immunomodulation; Increasing Donation; Inflammation; Organ Repair; Pediatrics; Solid Organs/Cells; Stem Cells; Transplant Complications; Transplantation

$25,000

Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: A pilot study

Co-investigatorCIHR2010Operating Grant

Principal investigators: Knoll, Gregory; Gill, John S; Humar, Atul

Keywords: Bk Virus Infection; Kidney Transplantation; Quinolone; Randomized Controlled Trial

$461,463

The BK: KIDNI Trial (BK: Kinase Inhibition to Decrease Nephropathy Intervention Trial)

Co-investigatorCIHR2009Randomized Controlled Trials

Principal investigators: Tibbles, Lee Anne; Hemmelgarn, Brenda R; Manns, Braden J

Keywords: Bk Virus; Chronic Allograft Nephropathy; Inflammation And Fibrosis; Randomized Controlled Clinical Trial; Sirolimus And Leflunomide; Transplant Failure

$3,319,686

Biological networks regulating organ transplantation outcome

Principal investigatorCIHR2008Catalyst Grant: Systems Biology Approaches to Immunotherapy

Principal investigators: Mui, Alice L; Keown, Paul A; McManus, Bruce M; McMaster, W. Robert; Ng, Raymond; Wilkinson, Mark D

Keywords: Gene Array; Graft Rejection; Immunosuppression; Metabolomics; Proteomics; Transplantation

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Paul Keown

Research

Latest papers

Latest funding

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry.

Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL.

HLA Experts' Perspectives on Precision Medicine and Molecular Matching in Kidney Transplantation: A Qualitative Study.

An integrative algorithm combining HLA epitope registry, PIRCHE-T2, and PIRCHE-B outcomes to improve immunological risk stratification in kidney transplantation.

Canadian Kidney Transplant Recipients', Transplant Candidates', and Caregivers' Perspectives on Precision Medicine and Molecular Matching in Kidney Allocation: A Qualitative Analysis.

The John Charnley Award: The Impact of Human Leukocyte Antigen Genotype on Bacterial Infection Rates and Successful Eradication in Total Hip Arthroplasty.

Are patients with primary glomerular disease at increased risk of malignancy?

Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure.

Canadian Kidney Transplant Professionals' Perspectives on Precision Medicine and Molecular Matching in Kidney Allocation.

NephroCAGE-German-Canadian Consortium on AI for Improved Kidney Transplantation Outcome: Protocol for an Algorithm Development and Validation Study.

Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection

Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss

The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes

Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: A pilot study

The BK: KIDNI Trial (BK: Kinase Inhibition to Decrease Nephropathy Intervention Trial)

Biological networks regulating organ transplantation outcome

Frequent collaborators

Ruth Sapir-Pichhadze

Stirling Bryan

David Landsberg

Marie-Chantal Fortin

Bruce McManus

Steven Shechter

Mypinder Sekhon

Ruth Sapir-Pichhadze

Sonya Cressman

James Lan

Sonya Cressman

Nilufar Partovi

Inna Sekirov

Bethany Foster

John Gill

Adeera Levin

Kathryn Tinckam

Sean Barbour

Raymond Ng

Diana Sherifali

Scott Tebbutt

Jagbir Gill

Timothy Caulfield